Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
UPC Universe Pharmaceuticals
- 0.1378
- +0.0058+4.39%
Close Mar 11 16:00 ET
- 0.1206
- -0.0172-12.48%
Post 20:01 ET
2.10MMarket Cap0.00P/E (TTM)
0.1400High0.1299Low521.00KVolume0.1400Open0.1320Pre Close69.21KTurnover3.59%Turnover RatioLossP/E (Static)15.23MShares64.800052wk High0.08P/B2.00MFloat Cap0.111052wk Low--Dividend TTM14.52MShs Float1079.1000Historical High--Div YieldTTM7.65%Amplitude0.1110Historical Low0.1320Avg Price1Lot Size
Universe Pharmaceuticals News
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | SCHEDULE 13G: Others
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Universe Pharmaceuticals | SCHEDULE 13G: Others
Universe Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Universe Pharmaceuticals | 424B5: Prospectus
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Universe Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]